NBIX insider transactions

Chief Human Resources Officer Cooke Julie exercised 24,965 shares at a strike of $81.49 and sold $5,770,235 worth of shares (36,937 units at $156.22) as part of a pre-agreed trading plan, decreasing direct ownership by 35% to 22,374 units (SEC Form 4)

Chief Medical Officer Keswani Sanjay Chandru converted options into 3,212 shares and covered exercise/tax liability with 1,733 shares (SEC Form 4) to satisfy tax liability

Chief Scientific Officer Onyia Jude exercised 11,000 shares at a strike of $84.74 and sold $1,762,710 worth of shares (11,000 units at $160.25) as part of a pre-agreed trading plan (SEC Form 4)

Chief Regulatory Officer Delaet Ingrid exercised 2,261 shares at a strike of $79.02 and sold $354,321 worth of shares (2,261 units at $156.71) as part of a pre-agreed trading plan (SEC Form 4)

Chief Scientific Officer Onyia Jude exercised 11,000 shares at a strike of $84.74 and sold $1,710,865 worth of shares (11,000 units at $155.53) as part of a pre-agreed trading plan (SEC Form 4)

SEC Form 4 filed by Director Gorman Kevin Charles

SEC Form 4 filed by Director Pops Richard F

SEC Form 4 filed by Director Lyons Gary A

SEC Form 4 filed by Director Mercier Johanna

SEC Form 4 filed by Director Poon Christine A

SEC Form 4 filed by Director Sharp Shalini

SEC Form 4 filed by Director Sherwin Stephen A

SEC Form 4 filed by Director Morrow George J

SEC Form 4 filed by Director Rastetter William H

SEC Form 4 filed by Director Norwalk Leslie V

Chief Corp. Affairs Officer Boyer David W. sold $609,023 worth of shares (3,888 units at $156.64) as part of a pre-agreed trading plan, decreasing direct ownership by 33% to 7,799 units (SEC Form 4)

Director Sherwin Stephen A converted options into 3,318 shares, increasing direct ownership by 26% to 15,860 units (SEC Form 4)

Director Sharp Shalini converted options into 1,659 shares, increasing direct ownership by 68% to 4,088 units (SEC Form 4)

Director Rastetter William H converted options into 3,318 shares, increasing direct ownership by 8% to 43,678 units (SEC Form 4)

Director Pops Richard F converted options into 3,318 shares, increasing direct ownership by 10% to 37,798 units (SEC Form 4)

Director Poon Christine A converted options into 3,318 shares, increasing direct ownership by 231% to 4,753 units (SEC Form 4)

Director Norwalk Leslie V converted options into 1,659 shares, increasing direct ownership by 68% to 4,088 units (SEC Form 4)

Director Morrow George J converted options into 3,318 shares, increasing direct ownership by 47% to 10,386 units (SEC Form 4)

Director Mercier Johanna converted options into 3,318 shares, increasing direct ownership by 94% to 6,853 units (SEC Form 4)

Director Lyons Gary A converted options into 1,659 shares, increasing direct ownership by 1% to 122,141 units (SEC Form 4)

Director Gorman Kevin Charles exercised 205,088 shares at a strike of $43.24 and sold $37,824,872 worth of shares (245,088 units at $154.33) as part of a pre-agreed trading plan, decreasing direct ownership by 7% to 511,293 units (SEC Form 4)

Director Pops Richard F exercised 15,000 shares at a strike of $47.89 and sold $2,364,760 worth of shares (15,000 units at $157.65) as part of a pre-agreed trading plan (SEC Form 4)

Director Norwalk Leslie V sold $590,601 worth of shares (3,810 units at $155.01) as part of a pre-agreed trading plan, decreasing direct ownership by 61% to 2,429 units (SEC Form 4)

New insider Ratz Andrew claimed ownership of 1,018 shares (SEC Form 3)

Chief Financial Officer Abernethy Matt gifted 2,249 shares, decreasing direct ownership by 5% to 42,808 units (SEC Form 4)

Chief Scientific Officer Onyia Jude gifted 3,110 shares, decreasing direct ownership by 11% to 25,670 units (SEC Form 4)

Chief Financial Officer Abernethy Matt converted options into 6,940 shares, covered exercise/tax liability with 9,124 shares and was granted 9,968 shares, increasing direct ownership by 21% to 44,881 units (SEC Form 4)

Chief Corp. Affairs Officer Boyer David W. covered exercise/tax liability with 8,052 shares, was granted 9,968 shares and converted options into 4,952 shares, increasing direct ownership by 146% to 11,581 units (SEC Form 4)

Chief Executive Officer Gano Kyle converted options into 9,714 shares, covered exercise/tax liability with 10,621 shares and was granted 9,968 shares, increasing direct ownership by 6% to 150,815 units (SEC Form 4)

Chief Scientific Officer Onyia Jude was granted 19,935 shares, converted options into 7,967 shares and covered exercise/tax liability with 15,099 shares, increasing direct ownership by 80% to 28,780 units (SEC Form 4)

Chief Commercial Officer Benevich Eric converted options into 6,049 shares, covered exercise/tax liability with 12,227 shares and was granted 16,613 shares, increasing direct ownership by 20% to 63,190 units (SEC Form 4)

Chief Human Resources Officer Cooke Julie was granted 9,968 shares, converted options into 4,298 shares and covered exercise/tax liability with 7,698 shares, increasing direct ownership by 24% to 34,170 units (SEC Form 4)

Chief Legal Officer Lippoldt Darin converted options into 5,892 shares, covered exercise/tax liability with 8,558 shares, was granted 9,968 shares and gifted 365 shares, increasing direct ownership by 15% to 54,729 units (SEC Form 4)

Chief Regulatory Officer Delaet Ingrid covered exercise/tax liability with 13,126 shares, was granted 19,935 shares and converted options into 4,360 shares, increasing direct ownership by 221% to 16,225 units (SEC Form 4)

Director Gorman Kevin Charles converted options into 10,981 shares, covered exercise/tax liability with 40,305 shares and was granted 63,724 shares, increasing direct ownership by 7% to 551,293 units (SEC Form 4)

SEC Form 4 filed by Chief Medical Officer Keswani Sanjay Chandru

Chief Corp. Affairs Officer Boyer David W. converted options into 2,096 shares and covered exercise/tax liability with 1,189 shares, increasing direct ownership by 24% to 4,713 units (SEC Form 4)

Chief Commercial Officer Benevich Eric converted options into 2,294 shares and covered exercise/tax liability with 1,292 shares, increasing direct ownership by 2% to 52,755 units (SEC Form 4)

Chief Financial Officer Abernethy Matt converted options into 2,437 shares and covered exercise/tax liability with 1,368 shares, increasing direct ownership by 3% to 37,097 units (SEC Form 4)

Chief Human Resources Officer Cooke Julie converted options into 1,741 shares and covered exercise/tax liability with 997 shares, increasing direct ownership by 3% to 27,602 units (SEC Form 4)

Chief Regulatory Officer Delaet Ingrid converted options into 801 shares and covered exercise/tax liability with 475 shares, increasing direct ownership by 7% to 5,056 units (SEC Form 4)

Chief Executive Officer Gano Kyle converted options into 2,927 shares and covered exercise/tax liability with 1,580 shares, increasing direct ownership by 0.96% to 141,754 units (SEC Form 4)

Director Gorman Kevin Charles covered exercise/tax liability with 2,845 shares and converted options into 5,142 shares, increasing direct ownership by 0.45% to 516,893 units (SEC Form 4)

Chief Legal Officer Lippoldt Darin converted options into 2,373 shares and covered exercise/tax liability with 1,335 shares, increasing direct ownership by 2% to 47,792 units (SEC Form 4)

Chief Scientific Officer Onyia Jude converted options into 238 shares and covered exercise/tax liability with 142 shares, increasing direct ownership by 0.60% to 15,977 units (SEC Form 4)

Chief Executive Officer Gano Kyle exercised 36,400 shares at a strike of $35.99 and sold $4,830,458 worth of shares (36,400 units at $132.70) (SEC Form 4)

Amendment: Chief Commercial Officer Benevich Eric exercised 12,830 shares at a strike of $35.99, increasing direct ownership by 29% to 57,723 units (SEC Form 4)

Chief Legal Officer Lippoldt Darin exercised 3,349 shares at a strike of $35.99, increasing direct ownership by 8% to 46,754 units (SEC Form 4)

Director Norwalk Leslie V exercised 10,000 shares at a strike of $91.07 and sold $945,702 worth of shares (6,190 units at $152.78), increasing direct ownership by 157% to 6,239 units (SEC Form 4)

Chief Legal Officer Lippoldt Darin exercised 4,376 shares at a strike of $43.24 and sold $698,615 worth of shares (4,376 units at $159.65) (SEC Form 4)

Director Lyons Gary A sold $2,289,082 worth of shares (15,000 units at $152.61) and exercised 15,000 shares at a strike of $47.89, increasing direct ownership by 12% to 135,482 units (SEC Form 4)

SEC Form 4 filed by Neurocrine Biosciences Inc.

Chief Scientific Officer Onyia Jude converted options into 4,426 shares and covered exercise/tax liability with 2,248 shares, increasing direct ownership by 16% to 15,881 units (SEC Form 4)

Director Morrow George J exercised 15,000 shares at a strike of $47.89 and sold $2,150,512 worth of shares (15,000 units at $143.37) (SEC Form 4)

Director Rastetter William H exercised 18,000 shares at a strike of $47.89 and sold $2,732,690 worth of shares (18,000 units at $151.82) (SEC Form 4)